Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tsuyoshi Shiio is active.

Publication


Featured researches published by Tsuyoshi Shiio.


Cell Biology International Reports | 1985

Cartilage-derived anti-tumor factor (CATF) inhibits the proliferation of endothelial cells in culture.

Masaharu Takigawa; Eiji Shirai; Motomi Enomoto; Yuji Hiraki; Michiko Fukuya; Fujio Suzuki; Tsuyoshi Shiio; Yasumi Yugari

Previous studies showed that a cartilage-derived anti-tumor factor (CATF), which was extracted from bovine cartilage with 1 M guanidine hydrochloride, inhibited the growth of solid sarcoma 180, but not the growth of ascites tumors of sarcoma 180 [Suzuki, F. et al. Jpn. J. Bone Metab., 2, 231-235 (1984)]. This study showed that CATF inhibited the proliferation and DNA synthesis of endothelial cells isolated from bovine pulmonary artery, but not the proliferations of sarcoma 180, L1210 and L cells. These results suggest that CATF has anti-angiogenic properties, thereby inhibiting the growth of solid tumors.


Journal of Bone and Mineral Metabolism | 1988

Cartilage-derived anti-tumor factor (CATF) - Partial purification and correlation of inhibitory activity against tumor growth with anti-angiogenic activity

Masaharu Takigawa; Eiji Shirai; Motomi Enomoto; Yuji Hiraki; Fujio Suzuki; Tsuyoshi Shiio; Yasumi Yugari

Cartilage-derived anti-tumor factor (CATF) inhibits the proliferation and DNA synthesis of bovine pulmonary artery endothelial (BPAE) cells in culture (Takigawa, M.et al. Cell. Biol. Inn. Rep., 9, 619–625, 1985). In the present study, we partially purified CATF by monitoring inhibition of DNA synthesis in BPAE cells and tested the effects of the purified materials on the growth of solid tumors and tumor-induced angiogenesis. Crude CATF (CATF20–300k), the fraction of 20 k to 300 k daltons, separated by ultrafiltration was further separated into three fractions by ultrafiltration. The fraction of 100 k to 300 k daltons (CATF100–300k) caused slightly more inhibition than CATF20–300k of DNA synthesis in BPAE cells. On the other hand, the fraction of 20 k to 50 k daltons had only a slight effect, and the fraction of 50 k to 100 k had even less effect on DNA synthesis in BPAE cells. CATF100–300k caused slightly more inhibition than CATF20–300k of the growth of solid tumors of B16 melanoma, while the fraction of 20 k to 100 k daltons did not inhibit the growth of tumors at all. CATF100–300k also inhibited B16 melanoma-induced angiogenesis in chick embryo chorioallantoic membranes (CAM), whereas the fraction of 20 k to 100 k daltons had little effect on the angiogenesis. CATF100–300k was further purified by DEAE-Sepharose CL-6B chromatography. The main peak with activity on DNA synthesis in BPAE cells was eluted with 0.3 to 0.35 M NaCl at pH 8.0. The activity of this peak on DNA synthesis in BPAE cells was about 70 fold that of CATF100–300k. The purified CATF also inhibited the growth of B16 melanoma and B16 melanoma-induced angiogenesis in CAM. On the other hand, the inactive fraction on DNA synthesis in BPAE cells obtained by DEAE-Sepharose chromatography was also inactive in inhibiting the growth of B16 melanoma and B16 melanoma-induced angiogenesis in CAM. These findings strongly suggest that CATF is an anionic macromolecule(s) and has anti-angiogenic activity, thereby inhibiting the growth of solid tumors.


The Journal of Antibiotics | 1983

MARINACTAN, ANTITUMOR POLYSACCHARIDE PRODUCED BY MARINE BACTERIA

Hamao Umezawa; Yoshiro Okami; Shogo Kurasawa; Takashi Ohnuki; Masaaki Ishizuka; Tomio Takeuchi; Tsuyoshi Shiio; Yasumi Yugari


The Journal of Antibiotics | 1983

New streptothricin-group antibiotics, AN-201 I and II. Screening, fermentation, isolation, structure and biological activity.

Shigeyoshi Miyashiro; Toshihiko Ando; Kazuo Hirayama; Takao Kida; Hiroshiro Shibai; Asao Murai; Tsuyoshi Shiio; Shigezo Udaka


Archive | 1976

Stable aqueous solutions of glucans and glucan derivatives capable of inhibiting sarcoma in mice

Mitsuharu Fujii; Tatsuo Kuoka; Tatsuo Setsuta; Yutaka Iwao; Yasumi Yugari; Tsuyoshi Shiio; Takashi Yoshihama; Junji Hamuro


Chemical & Pharmaceutical Bulletin | 1986

Synthesis and Antitumor Activity of cis-Dichloroplatinum Complexes Coordinating Nitrogen Cyclic or Sulfur Compounds

Tetsuo Osa; Hiroaki Hino; Shigeaki Fujieda; Tsuyoshi Shiio; Tetsuo Kono


The Journal of Antibiotics | 1983

The fermentation, isolation and characterization of a macromolecular peptide antibiotic: AN-3.

Shigeyoshi Miyashiro; Takao Kida; Hiroshiro Shibai; Tsuyoshi Shiio; Shigezo Udaka


The Journal of Antibiotics | 1984

THE FERMENTATION, ISOLATION AND CHARACTERIZATION OF MACROMOLECULAR PEPTIDE ANTIBIOTICS: AN-7A, -7B AND -7D

Shigeyoshi Miyashiro; Takao Kida; Hiroshiro Shibai; Tsuyoshi Shiio; Shigezo Udaka


Archive | 1983

Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments

Hamao Umezawa; Yoshiro Okami; Tomio Takeuchi; Shogo Kurasawa; Kazuhiko Yamada; Katsumi Suzuki; Tsuyoshi Shiio; Masaaki Ishizuka; Takashi Ohnuki


Archive | 1988

Platinum complexes and uses therewith

Seiichi Nishi; Kazuo Ohishi; Kunisuke Izawa; Tsuyoshi Shiio; Tetsuo Suami

Collaboration


Dive into the Tsuyoshi Shiio's collaboration.

Researchain Logo
Decentralizing Knowledge